201 related articles for article (PubMed ID: 32300432)
1. Vasculitis in Myelodysplastic Syndrome and Chronic Myelomonocytic Leukemia: A Report of Two Cases.
Jacobse J; Sijpkens YWJ; van 't Wout JW; Peters EEM; Vlasveld LT
J Hematol; 2018 Dec; 7(4):158-162. PubMed ID: 32300432
[TBL] [Abstract][Full Text] [Related]
2. Vasculitis associated with myelodysplastic syndrome and chronic myelomonocytic leukemia: French multicenter case-control study.
Roupie AL; Guedon A; Terrier B; Lahuna C; Jachiet V; Regent A; de Boysson H; Carrat F; Seguier J; Terriou L; Versini M; Queyrel V; Groh M; Benhamou Y; Maurier F; Ledoult E; Clech LL; D'Aveni M; Rossignol J; Galland J; Willems L; Chiche NJ; Peterlin P; Roux-Sauvat M; Parcelier A; Wemeau M; Lambert M; Belizna C; Puechal X; Swiader L; Cohen-Valensi R; Noc V; Dao E; Thepot S; de Frémont GM; Tanguy-Schmidt A; Koka AM; Bussone G; Philipponnet C; Konate A; Cavaille G; Guilpain P; Allain JS; Broner J; Solary E; Ruivard M; de Renzis B; Corm S; Baati N; Schleinitz N; Ponsoye M; Stamatoullas-Bastard A; Ades L; Dellal A; Tchirkov A; Aouba A; Fenaux P; Fain O; Mekinian A;
Semin Arthritis Rheum; 2020 Oct; 50(5):879-884. PubMed ID: 32896704
[TBL] [Abstract][Full Text] [Related]
3. [Systemic and autoimmune manifestations in myelodysplastic syndromes].
Fain O; Braun T; Stirnemann J; Fenaux P
Rev Med Interne; 2011 Sep; 32(9):552-9. PubMed ID: 20850913
[TBL] [Abstract][Full Text] [Related]
4. Increased cardiovascular comorbidities in patients with myelodysplastic syndromes and chronic myelomonocytic leukemia presenting with systemic inflammatory and autoimmune manifestations.
Kipfer B; Daikeler T; Kuchen S; Hallal M; Andina N; Allam R; Bonadies N
Semin Hematol; 2018 Oct; 55(4):242-247. PubMed ID: 30502853
[TBL] [Abstract][Full Text] [Related]
5. Systemic inflammatory and autoimmune manifestations associated with myelodysplastic syndromes and chronic myelomonocytic leukaemia: a French multicentre retrospective study.
Mekinian A; Grignano E; Braun T; Decaux O; Liozon E; Costedoat-Chalumeau N; Kahn JE; Hamidou M; Park S; Puéchal X; Toussirot E; Falgarone G; Launay D; Morel N; Trouiller S; Mathian A; Gombert B; Schoindre Y; Lioger B; De Wazieres B; Amoura Z; Buchdaul AL; Georgin-Lavialle S; Dion J; Madaule S; Raffray L; Cathebras P; Piette JC; Rose C; Ziza JM; Lortholary O; Montestruc F; Omouri M; Denis G; Rossignol J; Nimubona S; Adès L; Gardin C; Fenaux P; Fain O
Rheumatology (Oxford); 2016 Feb; 55(2):291-300. PubMed ID: 26350487
[TBL] [Abstract][Full Text] [Related]
6. Transformation of chronic myelomonocytic leukemia to acute lymphoblastic leukemia: case report and review of the literature of lymphoblastic transformation of myelodysplastic syndrome.
Kouides PA; Bennett JM
Am J Hematol; 1995 Jun; 49(2):157-62. PubMed ID: 7771469
[TBL] [Abstract][Full Text] [Related]
7. Myelodysplastic Syndromes (MDS) and autoimmune disorders (AD): cause or consequence?
Braun T; Fenaux P
Best Pract Res Clin Haematol; 2013 Dec; 26(4):327-36. PubMed ID: 24507810
[TBL] [Abstract][Full Text] [Related]
8. Large-vessel arteritis and myelodysplastic syndrome: report of two cases.
Steurer M; Fritsche G; Tzankov A; Gotwald T; Sturm W; Konwalinka G; Gruber J
Eur J Haematol; 2004 Aug; 73(2):128-33. PubMed ID: 15245512
[TBL] [Abstract][Full Text] [Related]
9. A case of chronic myelomonocytic leukemia complicated with spondyloarthritis.
Matsumoto T; Saito T; Kohsaka H
Mod Rheumatol; 2018 Mar; 28(2):373-375. PubMed ID: 26392142
[TBL] [Abstract][Full Text] [Related]
10. [Vasculitis associated with a myelodysplastic syndrome: a report of 5 cases].
Fernández-Miranda C; García-Marcilla A; Martín M; Gil R; Vanaclocha F; Torres N; del Palacio A
Med Clin (Barc); 1994 Oct; 103(14):539-42. PubMed ID: 7799667
[TBL] [Abstract][Full Text] [Related]
11. Systemic medium-sized vessel vasculitis associated with chronic myelomonocytic leukemia.
Hamidou MA; Boumalassa A; Larroche C; El Kouri D; Blétry O; Grolleau JY
Semin Arthritis Rheum; 2001 Oct; 31(2):119-26. PubMed ID: 11590581
[TBL] [Abstract][Full Text] [Related]
12. [Significance and application value of multiparameter flow cytometry for differentiation of immunophenotype in chronic myelomonocytic leukemia, myelodysplastic syndrome and acute monocytic leukemia].
Wang YX; Zhang JH; Hu YP; Cao FF; Zhang N; Chen F; Liu X; Zhang MY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Aug; 20(4):857-62. PubMed ID: 22931642
[TBL] [Abstract][Full Text] [Related]
13. Chronic myelomonocytic leukemia mimicking hematologic systemic lupus erythematosus.
Moura CA; Santiago M; Neto J; Gomes de Souza VH; Moura CG
Lupus; 2017 Feb; 26(2):204-207. PubMed ID: 27365372
[TBL] [Abstract][Full Text] [Related]
14. Targeted Next-Generation Sequencing in Myelodysplastic Syndrome and Chronic Myelomonocytic Leukemia Aids Diagnosis in Challenging Cases and Identifies Frequent Spliceosome Mutations in Transformed Acute Myeloid Leukemia.
Reinig E; Yang F; Traer E; Arora R; Brown S; Rattray R; Braziel R; Fan G; Press R; Dunlap J
Am J Clin Pathol; 2016 Apr; 145(4):497-506. PubMed ID: 27124934
[TBL] [Abstract][Full Text] [Related]
15. Eltrombopag Use in Patients With Chronic Myelomonocytic Leukemia (CMML): A Cautionary Tale.
Ramadan H; Duong VH; Al Ali N; Padron E; Zhang L; Lancet JE; List AF; Komrokji RS
Clin Lymphoma Myeloma Leuk; 2016 Aug; 16 Suppl():S64-6. PubMed ID: 27521328
[TBL] [Abstract][Full Text] [Related]
16. Autoimmune phenomena in patients with myelodysplastic syndromes and chronic myelomonocytic leukemia.
Saif MW; Hopkins JL; Gore SD
Leuk Lymphoma; 2002 Nov; 43(11):2083-92. PubMed ID: 12533032
[TBL] [Abstract][Full Text] [Related]
17. Autoimmune and inflammatory diseases associated with chronic myelomonocytic leukemia: A series of 26 cases and literature review.
Grignano E; Mekinian A; Braun T; Liozon E; Hamidou M; Decaux O; Puéchal X; Kahn JE; Schoindre Y; Rossignol J; Lortholary O; Lioger B; Hermine O; Park S; Ades L; Montestruc F; Ricard L; Gardin C; Fenaux P; Fain O;
Leuk Res; 2016 Aug; 47():136-41. PubMed ID: 27337291
[TBL] [Abstract][Full Text] [Related]
18. Platelet doubling after the first azacitidine cycle is a promising predictor for response in myelodysplastic syndromes (MDS), chronic myelomonocytic leukaemia (CMML) and acute myeloid leukaemia (AML) patients in the Dutch azacitidine compassionate named patient programme.
van der Helm LH; Alhan C; Wijermans PW; van Marwijk Kooy M; Schaafsma R; Biemond BJ; Beeker A; Hoogendoorn M; van Rees BP; de Weerdt O; Wegman J; Libourel WJ; Luykx-de Bakker SA; Minnema MC; Brouwer RE; Croon-de Boer F; Eefting M; Jie KS; van de Loosdrecht AA; Koedam J; Veeger NJ; Vellenga E; Huls G
Br J Haematol; 2011 Dec; 155(5):599-606. PubMed ID: 21981697
[TBL] [Abstract][Full Text] [Related]
19. Chronic myelomonocytic leukaemia (CMML)--a myelodysplastic or myeloproliferative syndrome?
Michaux JL; Martiat P
Leuk Lymphoma; 1993 Jan; 9(1-2):35-41. PubMed ID: 8477199
[TBL] [Abstract][Full Text] [Related]
20. [Clinical course, morphology and prognosis of chronic myelomonocytic leukemia].
Germing U; Strupp C; Meckenstock G; Giagounidis A; Minning H; Aul C
Med Klin (Munich); 1999 Sep; 94(9):467-72. PubMed ID: 10544608
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
